114 related articles for article (PubMed ID: 12750039)
21. Targeting of superantigens.
Kalland T; Dohlsten M; Abrahmsén L; Hedlund G; Björk P; Lando PA; Sundstedt A; Akerblom E; Lind P
Cell Biophys; 1993; 22(1-3):147-64. PubMed ID: 7889537
[TBL] [Abstract][Full Text] [Related]
22. An improved method of electrode placement in configuration Lead II for the reliable ECG recording by telemetry in the conscious rat.
Tontodonati M; Fasdelli N; Dorigatti R
J Pharmacol Toxicol Methods; 2011; 63(1):1-6. PubMed ID: 20332033
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP).
Kremer JJ; Bills AJ; Hanke NJ; Chen H; Meier WA; Osinski MA; Foley CM
J Pharmacol Toxicol Methods; 2015; 75():27-37. PubMed ID: 26001324
[TBL] [Abstract][Full Text] [Related]
24. Man-made superantigens: Tumor-selective agents for T-cell-based therapy.
Dohlsten M; Kalland T; Gunnarsson P; Antonsson P; Molander A; Olsson J; d'Argy R; Ohlsson L; Soegaard M; Persson R; Brodin TN
Adv Drug Deliv Rev; 1998 Apr; 31(1-2):131-142. PubMed ID: 10837621
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog.
Taylor GL; Patel B; Sullivan AT
J Pharmacol Toxicol Methods; 2007; 56(2):212-7. PubMed ID: 17582788
[TBL] [Abstract][Full Text] [Related]
26. Combined cardiopulmonary assessments with implantable telemetry device in conscious freely moving cynomolgus monkeys.
Authier S; Haefner P; Fournier S; Troncy E; Moon LB
J Pharmacol Toxicol Methods; 2010; 62(1):6-11. PubMed ID: 20570745
[TBL] [Abstract][Full Text] [Related]
27. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.
Prior H; McMahon N; Schofield J; Valentin JP
J Pharmacol Toxicol Methods; 2009; 60(2):167-73. PubMed ID: 19539041
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
[TBL] [Abstract][Full Text] [Related]
30. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
[TBL] [Abstract][Full Text] [Related]
31. Continuous evaluation of drug withdrawal in the rat using telemetry: effects of morphine and chlordiazepoxide.
Froger-Colléaux C; Rompion S; Guillaume P; Porsolt RD; Castagné V; Moser P
J Pharmacol Toxicol Methods; 2011; 64(1):81-8. PubMed ID: 21406242
[TBL] [Abstract][Full Text] [Related]
32. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
[TBL] [Abstract][Full Text] [Related]
33. Measurement of intraocular pressure by telemetry in conscious, unrestrained rabbits.
Schnell CR; Debon C; Percicot CL
Invest Ophthalmol Vis Sci; 1996 May; 37(6):958-65. PubMed ID: 8631639
[TBL] [Abstract][Full Text] [Related]
34. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
35. Comparison of freely-moving telemetry Chinese Miniature Experiment Pigs (CMEPs) to beagle dogs in cardiovascular safety pharmacology studies.
Yuan H; Zhao J; Guo J; Wu R; He L; Cui Y; Feng M; Zhang T; Hou M; Guo Q; Zhang L; Jia L; Huang C; Ye L; Peng S
J Pharmacol Toxicol Methods; 2014; 70(1):19-28. PubMed ID: 24721420
[TBL] [Abstract][Full Text] [Related]
36. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.
Bass AS; Hanson LA; Jackson TA
J Pharmacol Toxicol Methods; 2009; 60(1):51-7. PubMed ID: 19447184
[TBL] [Abstract][Full Text] [Related]
37. Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936.
Cheng JD; Babb JS; Langer C; Aamdal S; Robert F; Engelhardt LR; Fernberg O; Schiller J; Forsberg G; Alpaugh RK; Weiner LM; Rogatko A
J Clin Oncol; 2004 Feb; 22(4):602-9. PubMed ID: 14966084
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies and superantigens: a novel therapeutic approach.
Kalland T; Dohlsten M; Lind P; Sundstedt A; Abrahmsén L; Hedlund G; Björk P; Lando PA; Björklund M
Med Oncol Tumor Pharmacother; 1993; 10(1-2):37-47. PubMed ID: 8258993
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
Sundstedt A; Celander M; Ohman MW; Forsberg G; Hedlund G
Int Immunopharmacol; 2009 Aug; 9(9):1063-70. PubMed ID: 19410661
[TBL] [Abstract][Full Text] [Related]
40. Naptumomab estafenatox, an engineered antibody-superantigen fusion protein with low toxicity and reduced antigenicity.
Forsberg G; Skartved NJ; Wallén-Ohman M; Nyhlén HC; Behm K; Hedlund G; Nederman T
J Immunother; 2010 Jun; 33(5):492-9. PubMed ID: 20463598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
